Vagus Nerve Stimulator Market Expected To Rise At A CAGR Of 12.8% By 2026, Estimates DelveInsight - Seite 2

Vagus nerve stimulators are used for stimulation of the vagus nerve by the help of electrical impulses. A Vagus Nerve Stimulator that can be implanted has been approved by the FDA for both epilepsy and depression. In case of an implantable Vagus Nerve Stimulator, a device is implanted under the skin onto the chest region and a wire is threaded across that connects the device to the left area of the vagus nerve. There are two types of VNS, one which requires a surgical procedure for implantation (invasive) and the second which eliminates the need for surgical implantation (non–invasive). VNS devices find their application in various diseases such as Epilepsy, Depression, and Migraine. More recently few of the VNS devices which are in clinical stage are being studied for obesity such as ReShape vBloc therapy. Increasing incidence of neurological conditions, the resistance of patients to epileptic drugs or anti-depressants, technological advancements and escalating preferences for non-invasive devices are few of the driving factors responsible for high CAGR of the market over the forecast period. This, in turn, is expected to accelerate the demand of Vagus nerve stimulators across the world.

Key Competitors mentioned in Vagus Nerve Stimulators are:

• tVNS Technologies
• Parasym Ltd
• Electrocore Inc.
• LivaNova
• Soterix Medical
• NeuroSigma
• ReShape Lifesciences (formerly known as EnterMedics)
• NeuroPace
• MicroTransponder Inc.
• SetPoint Medical Corp
• Neuroceuticals

Know more about the key companies involved @ Vagus Nerve Stimulator Market Key Companies

Table of Content

1. Vagus Nerve Stimulator: Background and Overview
2. Vagus Nerve Stimulator Devices: Company Profiles
   - Company Overview
   - Product Portfolio
      -- Product description
      -- Regulatory Milestones
      -- Research and DevelopmentProduct Development Activities
3. Vagus Nerve Stimulator: Competitive Analysis
4. Vagus Nerve Stimulator: Eligible Patient Pool Analysis
   - VNS 7MM (2018–2026)
   - VNS US (2018–2026)
   - VNS UK (2018–2026)
   - VNS Germany (2018–2026)
   - VNS Spain (2018–2026)
   - VNS Italy (2018–2026)
   - VNS France (2018–2026)
   - VNS Japan (2018–2026)
5. Vagus Nerve Stimulator: Market Analysis
   - Vagus Nerve Stimulator 7MM (2018–2026)
   - Vagus Nerve Stimulator US (2018–2026)